| |
| |
|
| Insider
Information: |
Kozarich John W |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
128,523 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,661,092 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
128,523 |
|
|
| Total
Value |
$3,661,092 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-24 |
42,523 |
2006-01-04 |
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2015-06-29 |
57,000 |
2013-05-13 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
Director |
2019-05-08 |
29,000 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
officerTitle |
– • – |
2006-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,378 |
7,378 |
|
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2013-05-13 |
4 |
B |
$7.97 |
$79,700 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
12,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-05-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,000 |
12,378 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-19 |
4 |
B |
$3.45 |
$5,865 |
D/D |
1,700 |
13,700 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-17 |
4 |
B |
$9.90 |
$9,900 |
D/D |
1,000 |
13,726 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-08-13 |
4 |
B |
$6.01 |
$12,025 |
D/D |
2,000 |
14,378 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-08-29 |
4 |
B |
$6.14 |
$6,140 |
D/D |
1,000 |
15,378 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-24 |
4/A |
B |
$9.94 |
$32,056 |
D/D |
3,211 |
16,937 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-24 |
4 |
A |
$9.94 |
$32,056 |
D/D |
3,211 |
16,937 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-11-20 |
4 |
B |
$4.28 |
$8,560 |
D/D |
2,000 |
17,378 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-25 |
4 |
A |
$9.99 |
$17,872 |
D/D |
1,789 |
18,726 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-25 |
4/A |
B |
$9.99 |
$17,872 |
D/D |
1,789 |
18,726 |
2.39 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2008-03-05 |
4 |
B |
$3.66 |
$10,972 |
D/D |
3,000 |
20,378 |
2.39 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-22 |
4 |
B |
$3.62 |
$30,061 |
D/D |
8,300 |
22,000 |
2.39 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
22,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
24,500 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2008-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
25,378 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-05-14 |
4 |
S |
$112.92 |
$282,300 |
D/D |
(2,500) |
25,542 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,372 |
26,098 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-10-01 |
4 |
AS |
$275.04 |
$687,610 |
D/D |
(2,500) |
26,142 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
26,377 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
27,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-11-11 |
4 |
B |
$11.79 |
$11,787 |
D/D |
1,000 |
27,098 |
2.39 |
- |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
